BioSpace News Archive

The SWOG-nCartes EHR-to-EDC collaboration between nCoup and the SWOG Cancer Research Network was showcased at the Spring 2023 SWOG Hybrid Group Meeting earlier this month in San Francisco.

Adiso Therapeutics, Inc. today announced the completion of a Phase 1b multiple ascending dose (MAD) clinical trial evaluating ADS051 (BT051) an oral, gut-restricted, small molecule modulator of neutrophil trafficking and activation.

Ohh-Med, a medtech startup located in the Tiberias Industrial Zone, has developed Vertica, a medical device designed to improve the lives of thousands of men who experience erectile dysfunction (ED).

Manhattan Scientifics Inc. (OTCQB: MHTX), which provided the initial funding &, currently owns more than 50 million shares of Imagion Biosystems Ltd. celebrates Imagion’s remarkable progress in early cancer detection technology.

Armis Biopharma, Inc. announced today the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance for the VeriCyn® Wound Wash medical device. VeriCyn® Wound Wash provides skin-friendly wound care with a unique formula that is chlorine and surfactant free.

Nucleai, a leader in AI-powered spatial biology, and Adlai Nortye, a global biopharmaceutical company focused on developing innovative immuno-oncology therapies, today announced a strategic partnership to identify, validate and test novel H&E-based biomarkers across Adlai Nortye’s Phase 2 and 3 clinical trials.

DepYmed, Inc. (“DepYmed” or the “Company”) is a preclinical stage pharmaceutical company focused on developing transformative treatments for rare diseases and oncology that target the protein tyrosine phosphatase (PTP) family of enzymes.

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced that it will effect a 1-for-12 reverse stock split of its issued and outstanding common stock.

Getinge announces an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications.

To enhance the patient experience throughout a clinical trial journey, Alcanza Clinical Research, a mission-driven investigator site network, announces a partnership with Climb, a provider of digital clinical trial solutions.